about
Association of longevity with TNF-α G308A and IL-6 G174C polymorphic inflammatory biomarkers in Caucasians: a meta-analysis.-174G/C polymorphism in the interleukin-6 promoter is differently associated with prostate cancer incidence depending on race.Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cellsGenetic modulation of the interleukin 6 (IL-6) system in patients with advanced gastric cancer: a background for an alternative target therapy.Stressor-dependent Alterations in Glycoprotein 130: Implications for Glial Cell Reactivity, Cytokine Signaling and Ganglion Cell Health in GlaucomaInterleukin-6 in bone metastasis and cancer progression.Liver-inherent immune system: its role in blood-stage malaria.Elevated maternal soluble Gp130 and IL-6 levels and reduced Gp130 and SOCS-3 expressions in women complicated with preeclampsia.A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: a new approaches to neuroblastoma therapy (NANT) study.Altered interleukin-6 receptor, IL-6R and gp130, production and expression and decreased SOCS-3 expression in placentas from women with pre-eclampsia.Higher proliferation of peritumoral endothelial cells to IL-6/sIL-6R than tumoral endothelial cells in hepatocellular carcinoma.Social relationships and inflammatory markers: an analysis of Taiwan and the U.S.Soluble interleukin-6 receptor is elevated during influenza A virus infection and mediates the IL-6 and IL-32 inflammatory cytokine burst.Spatial regulation of interleukin-6 signaling in response to neurodegenerative stressors in the retina.Cytokines in chronic rheumatic diseases: is everything lack of homeostatic balance?Inflammation and stress-related candidate genes, plasma interleukin-6 levels, and longevity in older adults.Circulating soluble cytokine receptors and colorectal cancer risk.IL-6/IL-6R as a potential key signaling pathway in prostate cancer development.Integrated physiological mechanisms of exercise performance, adaptation, and maladaptation to heat stress.Keratoconus and crosslinking: pharmacokinetic considerations.Regulation of soluble interleukin-6 (IL-6) receptor release from corneal epithelial cells and its role in the ocular surface.Soluble IL-6 Receptor and IL-27 Subunit p28 Protein Complex Mediate the Antiviral Response through the Type III IFN Pathway.In vitro cytokine release profile: predictive value for metastatic potential in head and neck squamous cell carcinomasInterleukin-6 aborts lymphopoiesis and elevates production of myeloid cells in systemic lupus erythematosus-prone B6.Sle1.Yaa animals.Association between polymorphisms in selected inflammatory response genes and the risk of prostate cancer.IL6 blockade potentiates the anti-tumor effects of γ-secretase inhibitors in Notch3-expressing breast cancer.Bone Marrow Adipocyte: An Intimate Partner With Tumor Cells in Bone Metastasis.Heat Stroke
P2860
Q30251973-0035A154-1329-4F99-96AC-B861679E5CEEQ33684259-E306CEBE-0A3B-49C7-9F43-DE4736DF95AAQ33690450-5011CB57-2C15-43E5-B9C3-8482547691C4Q33714950-C0156241-FD1B-45D9-8E5D-8FC51E8C04DCQ33881495-45CFC723-20FB-4788-9AB1-B94357EB4503Q34051820-5CE743BB-51F6-4696-B3F4-D7582F289C46Q34449017-8C93FCCA-DA34-4528-A5F1-96A7AF7DF65AQ34707068-D65713B3-7D37-432F-A846-EF56E22A1617Q35050731-F2E2D2D8-4DD8-4A73-AAA1-38F67CF90951Q35738082-39FBC524-6136-42F8-876B-0346CCDEFB5FQ35829509-8AD600AE-790A-46FE-8BF4-CFECF5566303Q35946426-CAB521F0-D33C-482B-9599-9D8FC84C58C1Q36085075-D1172722-5168-4D6F-89B4-7E7330F1D3E9Q36576462-F60D3003-2DEA-47C4-9E0A-B4992B9C3555Q37453953-4151AA53-3C04-4CE9-AF39-5655BEC01BD0Q37470727-7E0F711F-F96B-4BC0-B4E2-992D10FFBCDDQ37625918-A07DAE43-8030-4EDD-BF35-03119CA385DEQ37968599-049F4FB0-C089-4B0E-AE8A-9CDBA6B7B1E6Q38111729-25807774-6C63-4448-9F94-8A9BA4935B34Q38133874-B993953F-6529-483C-85DD-B759379B12E6Q39552305-0F210469-9C9A-4CCB-A3F3-788891134634Q40621223-241D5CE1-3310-470C-819A-2439C1DD5B58Q41892370-5D529E20-49FA-45C1-ABDF-ED9CB2BE527CQ42086334-04419EDC-2BDC-4320-BEB5-1594C2C8F28AQ43083680-31957286-C788-4F48-A4FB-9254EB35DF7DQ48632592-4EED3943-35C4-4AC1-9487-0B37A441FE5EQ55655406-D4C5F7DF-7087-4A39-B9BD-03C1C414A2F3Q56003963-7BCD4991-3617-4852-8A21-7474BFB59A63
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
sIL-6R: more than an agonist?
@en
type
label
sIL-6R: more than an agonist?
@en
prefLabel
sIL-6R: more than an agonist?
@en
P2860
P356
P1476
sIL-6R: more than an agonist?
@en
P2093
Heike Knüpfer
Rainer Preiss
P2860
P356
10.1038/SJ.ICB.7100113
P577
2007-08-28T00:00:00Z